Mount Sinai Medical Center of Florida’s Post

The month of October is Breast Cancer Awareness Month, so let’s spread awareness on this issue! Let's stand with survivors, patients, and families affected by breast cancer. Early detection saves lives. Any one who live in Addis and Gonder please reach out to AlemFre Pink House Cancer Foundation 0948 06 04 06 for the Addis Ababa branch. Birara at 0942 41 85 58 for the Gonder branch. Every step counts in the fight against cancer. #breastcancerawareness #savelives #EarlyDetectionMatters #breastcancer #BreastCancerAwarenessMonth

Many barriers to tackle the breast cancer prevalence remain. Small incremental steps and larger overarching policies to make meaning full gains. Access to screening, diagnosis, timely care, time and access to therapeutic modalities (surgical/medical), risk reduction strategies crossing the barriers of race/ethnicity and SES...

Today is #WorldCancerDay, which recognizes the power of working together to reduce the global impact of cancer. At BCRF, we support international research all year long. Our 250+ researchers working across 15 countries are tackling every aspect of the disease, including BCRF investigators Drs. Sonya Reid and Lawrence Shulman. BCRF thanks The Estée Lauder Companies Inc. for supporting these two researchers. Click the link below for an exclusive conversation with Drs. Reid and Shulman discussing the urgent need to overcome global breast cancer disparities. https://bit.ly/47SlN2I

𝐈𝐍 𝐓𝐇𝐄 𝐍𝐄𝐖𝐒 𝐓𝐎𝐃𝐀𝐘 A global report on breast cancer, written by experts including those from Peter Mac, has praised the 40% decline in mortality in countries like Australia while warning that many women were still “systematically left behind”. The decline in mortality has occurred in many high-income countries over 30 years but is yet to be seen in most middle and low-income countries due to ongoing late diagnosis and treatment capacity issues. The Lancet Breast Cancer Commission – authored by Peter Mac’s Professor Kelly-Anne Phillips, Professor Prue Francis Francis and Dr Wanda Cui and international colleagues – says this is the world’s most common cancer with 2.3 million new cases in 2020. Read more: https://lnkd.in/gD_bvQzh

Are you actively working in #BreastCancer? Curious to see who are the Top 10 Sponsors in Breast Cancer - Ranked by Intelligencia AI Pipeline Performance Score? Take a look at this interesting report, which includes some valuable insights on which sponsors have the highest chances to succeed in the space.

In the words of Nelson Mandela “freedom cannot be achieved unless the women are emancipated from all forms of oppression “. This was my key takeaway thanks to this powerful session on the sidelines of the United Nations General Assembly convened by Marleen Temmerman. Starting with reflections on health system barriers and patient navigation by Miriam Mutebi, MD,MSc,FACS to a reminder of the burden of disease, widening disparities especially in low resource settings with the WHO Global Breast Cancer Initiative as a call to action by myself and a focused session on the drivers of disparities and existential gaps in research especially on political and economic determinants. It clearly emerged that the decision to attend care is greatly influenced by a woman’s time. In many families, women are the breadwinners and due to inequities in pay, they often they have to work for longer hours than their male counterparts hence lack time to attend their health needs. Therefore as we expand access to services, women’s empowerment and achievement of equity in this regard needs to be prioritized as these also have an impact on health outcomes. The need for designing breast programs that are context-specific. For example, for early detection and timely diagnosis, embracing technology and use of evidence-based innovative models of care that enable efficiency, saving on time for women and costs to the health system by @Susan Harvey. All in all, it was wonderful to take note of the fact that investments in women’s healthcare pays. I learnt that it is a trillion dollar market that has so far been underfunded, underserved and under researched through the life course. We have opportunity to shift the narrative, integrate private capital and bring everyone on board to drive this agenda. We know what needs to be done. Now its time to walk the talk and take multisectoral action… Dr Norah Akong'o Obudho (MD, MPH, PMD, PgMD) WomenLift Health Women in Global Health sharon Kapambwe Julie S. Torode Bente Mikkelsen Miriam Schneidman #equity #healthforall #SDGs #BreastCancerAwarenessMonth #PinkOctober

📣 Today! The GHTM session titled “Global disparities in breast cancer care: how to close the gap?” is about to start. At 10:30 am, join us and learn about the findings from the multi-country African Breast Cancer – Disparities in Outcomes (ABC-DO) study and record-linkage studies in Brazil; and join the discussion on the marked disparities in breast cancer survival and care between high-income and medium-/low-income countries   Read more about the topic of this session here: https://lnkd.in/debFVppB     See you there! #ghtm #ghtmsessions #breastcancer #globalsurvivaldisparity #globalhealth #tropicalmedicine

Join us in raising awareness for Brain Cancer this May! GBM is the most common and deadliest type of brain cancer in adults, with 95% of patients succumbing within five years of diagnosis. Your support can help us extend the reach of GBM AGILE to Asian patients and beyond. As co-founders of the innovative and paradigm-changing clinical trial system, #GBMAGILE, AFCR is committed to pioneering innovative treatments for brain cancer, particularly #Glioblastoma (#GBM). Together, we're providing real hope for patients battling GBM. Donate today and be a part of saving lives: https://lnkd.in/eWUzr9JY #AFCR #BrainCancerAwareness #BrainCancer #HopeForGBM #FightAgainstCancer #ClinicalTrials #DonateNow

🧡 Stand Up To Cancer Day 🧡 Today, we come together to honour those who have battled cancer, support those who are fighting, and remember those we have lost. Every step forward in research, treatment, and support brings us closer to a cure. Together, we can make a difference by: • Supporting groundbreaking research • Raising awareness • Standing by those battling cancer ➡️🖱️For advice, support or information on how you can show your support, we’ve put some links below: Stand Up To Cancer: https://lnkd.in/dQ7AhG5U Macmillan Cancer Support: https://lnkd.in/gmfbxP7 Cancer Research: https://lnkd.in/dYCMrZq #StandUpToCancerDay #CancerAwareness #ResearchMatters

Exciting news for #OneChain! 🎉 Our founder Pablo Menendez Bujan and research director Víctor Manuel Díaz Cortés had the privilege of attending the Association Against Cancer's aid award ceremony in Barcelona last Thursday. This event underscored the ongoing commitment to cancer research, and for us, marked a particularly significant milestone: OneChain has been awarded a grant of €450,000 for the development of a new CAR T therapy targeting a rare subtype of leukemia with no therapeutic alternatives.   Our endeavor aligns with the Association's goal to boost cancer survival rates to 70% by 2030, highlighting the critical need to bring research outcomes directly to the patients who need them the most. We extend our gratitude to the Association Against Cancer for their generous support and for recognizing the potential of our research. This achievement reinforces our commitment to advancing science and offering new hope to patients facing unprecedented challenges in their treatment.   Together, we are making a difference! Asociación Española Contra el Cáncer   #Innovation #CARTTherapy #FightingCancer #CancerResearch.